type II diabetes5. However, like most proteases, a complete picture of the targets of DPP4 is lacking, which makes it difficult to anticipate metabolic function has prompted the development of a number of small-molecule inhibitors of DPP4, including sitagliptin (Januvia), which was recently approved by the US Food Proteases are enzymes that perform the basic task of cutting up other proteins an...